Table 1.
Patients included in this study. Abbreviations: F = female; M = male; MRI = magnetic resonance imaging; n.a. = not available; very right column indicated postoperative seizure outcome according to Engel's classification scheme. 15 Two patients (asterisk in very left column) have been re‐operated in 2014 with outcome data not yet available. Second resection showed neuropathologically remnants of oligodendroglial hyperplasia in these two cases. Antiepileptic drug (AED) medication; CBZ = Carbamazepine; CLB = Clobazam; CNZ = Clonazepam; ESM = Ethosuximide; GBP = Gabapentin; LCM = Lacosamide; LEV = Levetiracetam; LTG = Lamotrigine; MSX = Mesuximide; OXC = Oxcarbazepine; PB = Phenobarbital; PGN = Pregabalin; PHT = Phenytoin; PRM = Primidone; RUF = Rufinamide; STM = Sultiame; TPM = Topiramate; VGB = Vigabatrine; VPA = Valproic Acid; ZNS = Zonisamide.
| Patient ID | Gender | Side of resection | Localization | Onset of epilepsy (years) | Duration of epilepsy (years) | Age at surgery (years) | Diagnosis (MRI) | AED | Post‐Op outcome (Engel) |
|---|---|---|---|---|---|---|---|---|---|
| P1 | M | left | frontal | 13 | 5 | 18 | FCD | CBZ, LEV, LTG, TPM.VPA | I |
| P2 | M | right | frontal | 0,7 | 2,6 | 3 | FCD | ESM, LEV | n.a. |
| P3 | F | right | frontal | 1 | 1 | 2 | FCD | CBZ, CNZ, OXC, LEV, TPM, VGB, VPA | III |
| P4 | M | left | frontal | 1 | 3 | 4 | FCD | n.a. | n.a. |
| P5 | M | right | frontal | 2 | 13 | 15 | FCD | CLB, ESM, OXC, PB, TPM, STM, VGB, VPA | III |
| P6* | F | left | frontal | 0,3 | 9,7 | 10 | FCD | CBZ, LCM, LEV, LTG, MSX, OXC, PHT, STM, TPM, VGB, VPA, ZNS | III |
| P7 | M | left | frontal | 2 | 2 | 4 | FCD | CLB, LEV, LTG, STM, VGB, VPA | II |
| P8 | F | right | frontal | 1 | 18 | 19 | FCD | CBZ, CLB, GBP, LEV, LTG, MSX, OXC, PB, PHT, STM, TPM, VGB, VPA | III |
| P9 | F | right | frontal | 13 | 36 | 49 | FCD | n.a. | n.a. |
| P10 | M | left | frontal | 2 | 5 | 7 | FCD | CLB, LTG, OXC | Ill |
| P11 | M | left | frontal | 1,5 | 15,5 | 17 | FCD | ESM, LEV, OXC, TPM, VPA | III |
| P12 | F | right | frontal | 0,3 | 4,7 | 5 | FCD | CLB, ESM, LEV, LTG, TPM, VPA | I |
| P13* | M | right | frontal | 4 | 23 | 27 | FCD | CLB.LCM, LEV, LTG | III |
| P14 | F | left | frontal | 10 | 8 | 18 | FCD | ESM, LTG | IV |
| P15 | M | right | frontal | 11 | 35 | 46 | FCD | CBZ, LCM, LTG, PB, PHT, PGN, STM, VGB, VPA | III |
| P16 | F | right | frontal | 1 | 3 | 4 | FCD | LEV, TPM, OXC, STM, VGB, VPA | I |
| P17 | M | left | frontal | 5 | 24 | 29 | FCD | CBZ, LCM,LEV,PHT,VPA | I |
| P18 | M | left | frontal | 0,5 | 3,5 | 4 | FCD | LEV, LTG, OXC, STM, VGB, VPA | I |
| P19 | M | left | frontal | 2,5 | 13,5 | 16 | FCD | LTG, VPA | III |
| P20 | M | right | frontal | 12 | 10 | 22 | FCD | LCM, LEV, OXC, ZNS | III |
| P21 | F | right | frontal | 6 | 5 | 11 | FCD | ESM, LEV, OXC, RUF, VPA | n.a. |
| P22 | M | right | frontal | 4 | 19 | 22 | FCD | LEV, OXC, PRM, STM, VGB, VPA | I |